Showing 1 - 12 results of 12 for search 'Jay S Schneider', query time: 0.04s Refine Results
  1. 1
    GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms

    GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mecha... by Jay S. Schneider

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.

    Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease. by Jay S Schneider

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Altered expression of glycobiology-related genes in Parkinson’s disease brain

    Altered expression of glycobiology-related genes in Parkinson’s disease brain by Jay S. Schneider, Garima Singh

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease.

    Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson's Disease. by Jay S Schneider, Stephanie Sendek, Chengwu Yang

    Published 2015-01-01
    Get full text
    Article
  5. 5
    β2⁎ and β4⁎ nicotinic acetylcholine receptor expression changes with progressive parkinsonism in non-human primates

    β2⁎ and β4⁎ nicotinic acetylcholine receptor expression changes with progressive parkinsonism in non-human primates by Jennifer M. Kulak, Hong Fan, Jay S. Schneider

    Published 2007-09-01
    Get full text
    Article
  6. 6
    Different Behavioral Experiences Produce Distinctive Parallel Changes in, and Correlate With, Frontal Cortex and Hippocampal Global Post-translational Histone Levels

    Different Behavioral Experiences Produce Distinctive Parallel Changes in, and Correlate With, Frontal Cortex and Hippocampal Global Post-translational Histone Levels by Marissa Sobolewski, Garima Singh, Jay S. Schneider, Deborah A. Cory-Slechta

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.

    Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease. by Jay S Schneider, Thomas N Seyfried, Hyo-S Choi, Sarah K Kidd

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Increased Attack Rates and Decreased Incubation Periods in Raccoons with Chronic Wasting Disease Passaged through Meadow Voles

    Increased Attack Rates and Decreased Incubation Periods in Raccoons with Chronic Wasting Disease Passaged through Meadow Voles by S. Jo Moore, Christina M. Carlson, Jay R. Schneider, Christopher J. Johnson, Justin J. Greenlee

    Published 2022-04-01
    Get full text
    Article
  9. 9
    Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.

    Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent... by Julie Nemecek, Nabanita Nag, Christina M Carlson, Jay R Schneider, Dennis M Heisey, Christopher J Johnson, David M Asher, Luisa Gregori

    Published 2013-01-01
    Get full text
    Article
  10. 10
    No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.

    No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial. by Chizoba C Umeh, Adriana Pérez, Erika F Augustine, Rohit Dhall, Richard B Dewey, Zoltan Mari, David K Simon, Anne-Marie A Wills, Chadwick W Christine, Jay S Schneider, Oksana Suchowersky

    Published 2014-01-01
    Get full text
    Article
  11. 11
    SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19.

    SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. by Daniel J Clemens, Dan Ye, Wei Zhou, C S John Kim, David R Pease, Chanakha K Navaratnarajah, Alison Barkhymer, David J Tester, Timothy J Nelson, Roberto Cattaneo, Jay W Schneider, Michael J Ackerman

    Published 2023-01-01
    Get full text
    Article
  12. 12
    Plants as vectors for environmental prion transmission

    Plants as vectors for environmental prion transmission by Christina M. Carlson, Samuel Thomas, Matthew W. Keating, Paulina Soto, Nicole M. Gibbs, Haeyoon Chang, Jamie K. Wiepz, Annabel G. Austin, Jay R. Schneider, Rodrigo Morales, Christopher J. Johnson, Joel A. Pedersen

    Published 2023-12-01
    Get full text
    Article

Search Tools: